Organigram Global Inc. (OGI) Sees C$4 Target on Improved Outlook

Group 1 - Organigram Global Inc. (NASDAQ:OGI) is recognized as one of the best pot stocks to buy according to hedge funds, with 7 hedge funds holding stakes in the company as of Q3 2025 [5] - Canaccord raised its price target for Organigram to C$4 from C$3 while maintaining a Buy rating, indicating improved market outlook [2][8] - The company announced a subscription agreement with BT DE Investments, a subsidiary of British American Tobacco, for the acquisition of Sanity Group, which includes a subscription for 14,027,074 shares at C$3.00 per share, totaling approximately C$65.2 million [3] Group 2 - Organigram is expanding its international portfolio by launching Edison and BOXHOT medical cannabis vape and pastille SKUs in Australia, enhancing its product mix and market penetration [4] - Founded in 2013 and headquartered in Moncton, New Brunswick, Organigram focuses on innovation, branded cannabis products, and international expansion [5]